SF 5290 introduced

Addition requirement for certain pharmaceutical marketing expenses

Type: bill Introduced: May 13, 2026 Last action: May 14, 2026 👁 4 views

📌 Latest Action

Referred to Taxes

🏷️ Topics

"Taxation Taxation-Corporate Taxation-Income"
Raw Data (for developers)
{"id": "ocd-bill/39dc8441-788a-48e9-ac1e-fd1ce2e76a26", "session": "2025-2026", "jurisdiction": {"id": "ocd-jurisdiction/country:us/state:mn/government", "name": "Minnesota", "classification": "state"}, "from_organization": {"id": "ocd-organization/6a026144-758d-4d57-b856-9c60dce3c4b5", "name": "Senate", "classification": "upper"}, "identifier": "SF 5290", "title": "Addition requirement for certain pharmaceutical marketing expenses", "classification": ["bill"], "subject": ["Taxation", "Taxation-Corporate", "Taxation-Income"], "extras": {}, "created_at": "2026-05-13T01:10:37.913861+00:00", "updated_at": "2026-05-14T16:38:19.707580+00:00", "openstates_url": "https://openstates.org/mn/bills/2025-2026/SF5290/", "first_action_date": "2026-05-13", "latest_action_date": "2026-05-13", "latest_action_description": "Referred to Taxes", "latest_passage_date": ""}